Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)

Mylan Pharma UK Ltd. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
copd
copd, revefenacin, long-acting muscarinic receptor antagonist(lama), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 864094
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.